Spots Global Cancer Trial Database for unresectable thymic carcinoma
Every month we try and update this database with for unresectable thymic carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer | NCT03295227 | Stage III Thymo... Stage IIIA Thym... Stage IIIB Thym... Stage IV Thymom... Stage IVA Thymo... Stage IVB Thymo... Unresectable Th... | Pembrolizumab | 18 Years - | M.D. Anderson Cancer Center | |
Carboplatin and Paclitaxel With or Without Ramucirumab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Thymic Cancer That Cannot Be Removed by Surgery | NCT03694002 | Locally Advance... Metastatic Thym... Recurrent Thymi... Unresectable Th... | Carboplatin Paclitaxel Ramucirumab | 18 Years - | SWOG Cancer Research Network |